| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $43.2M | -27.6% |
| Cost of Revenue | $20.9M | -38.4% |
| Gross Profit | $22.3M | -13.3% |
| R&D Expense | $31.3M | +1.5% |
| SG&A Expense | $20.7M | -11.8% |
| Operating Income | -$31.4M | -9.5% |
| Interest Expense | $69K | +176.0% |
| Pre-tax Income | -$29.1M | -9.3% |
| Income Tax | $478K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $23.6M | -50.3% |
| Accounts Receivable | $5.8M | -42.4% |
| Inventory | $4.2M | +6.1% |
| Current Assets | $34.9M | -46.2% |
| Total Assets | $64.1M | -33.2% |
| Current Liabilities | $8.3M | -32.1% |
| Total Liabilities | $24.2M | -21.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.8M | -5.3% |
| Capital Expenditures | $3.8M | -1.9% |
| Investing Cash Flow | -$3.1M | +21.8% |
| Financing Cash Flow | -$971K | -107.2% |
| Free Cash Flow | -$23.6M | -4.1% |
| +33.9% |
| Net Income | -$28.7M | -9.7% |
| EPS (Basic) | -$0.49 | -4.3% |
| EPS (Diluted) | -$0.49 | -4.3% |
| Stockholders' Equity |
| -$10.6M |
| -184.3% |